India's Sun Pharma Advanced Research rises to over 1.5-year high
** Shares of Sun Pharma Advanced Research SPRC.NS rise as
much as 8% to 277.85 rupees, highest since April 22, 2022
** Stock on track to post highest monthly gain since May
2021, if trends hold
** Stock has been above its 50-day, 100-day, and 200-day
simple moving avgs of since Nov. 9, indicating bullish sentiment
** Trading vol is 5.1x the 30-day daily avg, tops 6 mln for
the first time since Nov. 9
** SRPC traded most since Aug. 30
** Stock up 7% as of 10:47 a.m. IST, extending YTD gains to
~32%
(Reporting by Anuran Sadhu in Bengaluru)
((Anuran.Sadhu@thomsonreuters.com ;))
Recent news on Sun Pharma Advanced Research
See all newsAdvisory: Alert incorrectly tagged to Sun Pharma Advanced Research withdrawn
Brief: Sun Pharma Advanced Research Appoints Anil Raghavan As MD And CEO Effective August 11
Brief: Sun Pharma Advanced Research Says Ocuvex Therapeutics Gets Complete Response Letter For PDP-716 NDA
India's Sun Pharma Advanced Research jumps after swinging to Q4 profit
Brief: Sun Pharma Advanced Research March-Quarter Consol Profit 17.61 Billion Rupees